Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent Mitophagy.
Murakami K, Kurotaki D, Kawase W, Soma S, Fukuchi Y, Kunimoto H, Yoshimi R, Koide S, Oshima M, Hishiki T, Hayakawa N, Matsuura T, Oda M, Yanagisawa K, Kobayashi H, Haraguchi M, Atobe Y, Funakoshi K, Iwama A, Takubo K, Okamoto S, Tamura T, Nakajima H. Murakami K, et al. Cell Rep. 2021 Jan 5;34(1):108579. doi: 10.1016/j.celrep.2020.108579. Cell Rep. 2021. PMID: 33406421 Free article.
Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis.
Murakami K, Kohashi S, Sakurai M, Kato J, Toyama T, Koda Y, Yamane Y, Hashida R, Abe R, Yamazaki R, Kikuchi T, Shimizu T, Suzuki S, Hasegawa N, Okamoto S, Mori T. Murakami K, et al. Int J Hematol. 2017 Sep;106(3):436-440. doi: 10.1007/s12185-017-2254-9. Epub 2017 May 13. Int J Hematol. 2017. PMID: 28501929
Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention.
Shiroshita K, Mori T, Kato J, Sakurai M, Koda Y, Abe R, Murakami K, Sumiya C, Fujita S, Yamaguchi K, Yamazaki R, Nakayama H, Suzuki S, Nakahara J, Okamoto S. Shiroshita K, et al. Among authors: murakami k. Bone Marrow Transplant. 2020 May;55(5):939-945. doi: 10.1038/s41409-019-0755-2. Epub 2019 Nov 21. Bone Marrow Transplant. 2020. PMID: 31754252
Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7.
Kunimoto H, Fukuchi Y, Murakami K, Ikeda J, Teranaka H, Kato I, Miyazaki T, Enaka M, Mitsuhashi T, Yamazaki E, Kameyama K, Murata M, Okamoto S, Nakajima H. Kunimoto H, et al. Among authors: murakami k. Hemasphere. 2020 Sep 17;4(5):e469. doi: 10.1097/HS9.0000000000000469. eCollection 2020 Oct. Hemasphere. 2020. PMID: 33163905 Free PMC article.
Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patients.
Harada I, Sasaki H, Murakami K, Nishiyama A, Nakabayashi J, Ichino M, Miyazaki T, Kumagai K, Matsumoto K, Hagihara M, Kawase W, Tachibana T, Tanaka M, Saito T, Kanamori H, Fujita H, Fujisawa S, Nakajima H, Tamura T. Harada I, et al. Among authors: murakami k. Sci Rep. 2021 Sep 10;11(1):18046. doi: 10.1038/s41598-021-97371-8. Sci Rep. 2021. PMID: 34508131 Free PMC article.
MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis.
Hayashi Y, Kawabata KC, Tanaka Y, Uehara Y, Mabuchi Y, Murakami K, Nishiyama A, Kiryu S, Yoshioka Y, Ota Y, Sugiyama T, Mikami K, Tamura M, Fukushima T, Asada S, Takeda R, Kunisaki Y, Fukuyama T, Yokoyama K, Uchida T, Hagihara M, Ohno N, Usuki K, Tojo A, Katayama Y, Goyama S, Arai F, Tamura T, Nagasawa T, Ochiya T, Inoue D, Kitamura T. Hayashi Y, et al. Among authors: murakami k. Cell Rep. 2022 May 10;39(6):110805. doi: 10.1016/j.celrep.2022.110805. Cell Rep. 2022. PMID: 35545056 Free article.
4,528 results